ANN ARBOR, Mich., June 15 /PRNewswire/ -- As it prepares to move into clinical trials on a new drug for osteoporosis, Velcura Therapeutics, Inc. has chosen to work with Hurley Consulting Associates Ltd., which will assist the biotech company with the development program design, FDA submissions and clinical trial data collection and analysis. Hurley Consulting already has successfully worked with sponsors in designing development programs and prepared osteoporosis new drug applications (NDAs) for submission in the U.S. and Europe.
